Associate Professor, Medicine, UCLA School of Medicine
Gastroenterology
Dr. Mark Pimentel, MD
|
|
Give Review
Dr. Mark Pimentel practices Gastroenterology. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Mark Pimentel is a published physician as well. He has 34 publications published. The latest was: Understanding Breath Tests for Small Intestinal Bacterial Overgrowth. Mark Pimentel accepts Medicare payments and is registered with Medicare.gov.
Publications
- Metabolic effects of eradicating breath methane using antibiotics in prediabetic subjects with obesity.
- Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders.
- Inclusion Of A Novel Ibs Blood Panel For Diagnosing Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D): A Uk Perspective.
- A Novel Ibs Diagnostic Blood Panel Can Enhance A Positive Diagnostic Strategy Versus A Strategy Of Exclusion For Patients With Diarrhea Predominant Irritable Bowel Syn...
- Cost-Minimization For A Novel Ibs Diagnostic Blood Panel Versus Standard Exclusionary Diagnostic Testing For Diarrhea Predominant Irritable Bowel Syndrome: A United St...
- Impact Of A Novel Ibs Diagnostic Blood Panel For Mexico: Cost Implications To The Mexican Private Practice For Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D).
- Potential For Cost Savings Associated With A Novel Ibs Blood Panel For Diagnosing Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D): Italian Perspective.
- Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model.
- GastroEsophageal Reflux Reported on Esophagram Does Not Correlate with pH Monitoring and High-resolution Esophageal Manometry.
- Editorial: safety and tolerability of rifaximin for IBS - more information is required; authors' reply.
- Safety and tolerability of rifaximin for the treatment of irritable bowel Syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-control...
- Antibiotic Treatment of Constipation-Predominant Irritable Bowel Syndrome.
- Probiotics for Antibiotic-Associated Diarrhea: PLACIDE Swings the Pendulum.
- Placebo Effect in Clinical Trial Design for Irritable Bowel Syndrome.
- Evaluating the functional net value of pharmacologic agents in treating irritable bowel Syndrome.
- Methanogens, Methane and GastroIntestinal Motility.
- Adverse events appear to unblind clinical trials in irritable bowel Syndrome.
- Gas and the microbiome.
- Measuring response in the gastrointestinal tract in Systemic sclerosis.
- Recorded lower esophageal pressures as a function of electronic sleeve placement and location of gastric pressure measurement in patients with Hiatal hernia.
- GastroIntestinal bacterial overgrowth: pathogenesis and clinical significance.
- Evaluation of peripapillary lymphocytosis and lymphocytic esophagitis in adult inflammatory bowel Disease.
- Report from the multinational irritable bowel Syndrome initiative 2012.
- Intestinal Methanobrevibacter smithii but not total bacteria is related to diet-induced weight gain in rats.
- Methane and hydrogen positivity on breath test is associated with greater body mass index and body fat.
- Effect of repeated Campylobacter jejuni infection on gut flora and mucosal defense in a rat model of post infectious functional and microbial Bowel changes.
- Severity of dyspeptic symptoms correlates with delayed and early variables of Gastric emptying.
- Methanobrevibacter smithii is the predominant methanogen in patients with constipation-predominant IBS and methane on breath.
- Evaluating breath methane as a diagnostic test for constipation-predominant IBS.
- New clinical method for distinguishing D-IBS from other gastroIntestinal conditions causing diarrhea: the LA/IBS diagnostic strategy.
- Psychological disorders in gastrointestinal Disease: epiphenomenon, cause or consequence?
- Healthy control subjects are poorly defined in case-control studies of irritable bowel Syndrome.
- Understanding Breath Tests for Small Intestinal Bacterial Overgrowth.
Schools
University of Manitoba Faculty of Medicine
University Of California Los Angeles
Procedures Preformed
- Anoscopy
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Manometry
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
UCLA Medical Center -
University of Manitoba
Hospital
-
Ronald Reagan UCLA Medical Center -
Cedars-Sinai Medical Center
Drug Facts
| NPI NUMBER | 1750319356 | |
| NPPES Provider LastName | PIMENTEL | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 900481865 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 422.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1750319356 |
| Last Name Of The Provider | PIMENTEL |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
Dr. Benjamin Basseri, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward J. Feldman, MD |
|
|
Dr. Siamak Tabib, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ariel Malamud, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Parviz Javdan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Woojin Kim, MD |
|
|
Dr. Hyo-Rang Lee, MD |
|
|
Dr. John A. Lunn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul J. Korc, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chris N. Conteas, MD
This Doctor is OpenDoctor Recommended.
|